This compound is a pharmaceutical intermediate used in the manufacturing of the apalutamide metabolite. It is a carboxylic acid derivative containing a fluoro-substituted aromatic ring and a cyclobutane ring.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2170654-26-7
1-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutane-1-carboxylic acid
Apalutamide active metabolite M19
Methyl 1-[3-fluoro-4-(methylcarbamoyl)anilino]cyclobutane-1-carboxylate
pharmaceutical intermediate for apalutamide
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
Tert-butyl 4-methylsulfanyl-10-oxospiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
pharmaceutical intermediate
Trilaciclib Impurity 3
Pharmaceutical impurity reference standard
Trilaciclib Impurity 35
Trilaciclib intermediate for pharmaceutical synthesis
4-((1-Cyanocyclobutyl)amino)-2-fluoro-N-methylbenzamide
pharmaceutical intermediate
1-[3-fluoro-4-(methylcarbamoyl)anilino]cyclobutane-1-carboxylic acid
FGOGELABKVPEAL-UHFFFAOYSA-N
CNC(=O)C1=C(C=C(C=C1)NC2(CCC2)C(=O)O)F